Aclaris Therapeutics, Inc.
Ticker: 1557746
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 2.00-39.4% | 3.30+85.4% | 1.78+21.9% | 1.46-66.4% | 4.35+57.0% | 2.77+15.4% | 2.40-74.1% | 9.28 |
| Total Income | 2.00-39.4% | 3.30+85.4% | 1.78+21.9% | 1.46-66.4% | 4.35+57.0% | 2.77+15.4% | 2.40-74.1% | 9.28 |
| EXPENSES | ||||||||
| Expenditure | 24.19+18.3% | 20.45+1.3% | 20.19+3.3% | 19.54+31.8% | 14.82-5.1% | 15.62-26.8% | 21.33-47.8% | 40.86 |
| PROFIT | ||||||||
| PBT | — | -14.61+5.3% | -15.43-2.3% | -15.09 | — | — | — | — |
| Net Profit | -19.82-35.7% | -14.61+5.3% | -15.43-2.3% | -15.09-98.8% | -7.59+30.9% | -10.99+35.1% | -16.94+42.1% | -29.26 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | -0.15-25.0% | -0.12+7.7% | -0.13-8.3% | -0.12-9.1% | -0.11+26.7% | -0.15+37.5% | -0.24+41.5% | -0.41 |
Corporate Events
Board MeetingACRS
20264Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect directors, appr…
SEC Filing ↗